Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL(pro)

The COVID-19 has now been declared a global pandemic by the World Health Organization. No approved drug is currently available; therefore, an urgent need has been developed for any antiviral therapy for COVID-19. Main protease 3CL(pro) of this novel Coronavirus (SARS-CoV-2) play a critical role in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vincent, Savariar, Arokiyaraj, Selvaraj, Saravanan, Muthupandian, Dhanraj, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785853/
https://www.ncbi.nlm.nih.gov/pubmed/33425994
http://dx.doi.org/10.3389/fmolb.2020.613401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785853/
https://www.ncbi.nlm.nih.gov/pubmed/33425994
http://dx.doi.org/10.3389/fmolb.2020.613401

Ejemplares similares